PT1117676E - Derivados de propanolamina ligados a acidos biliares para o tratamento de disturbios no metabolismo dos lipidicos - Google Patents

Derivados de propanolamina ligados a acidos biliares para o tratamento de disturbios no metabolismo dos lipidicos

Info

Publication number
PT1117676E
PT1117676E PT99947385T PT99947385T PT1117676E PT 1117676 E PT1117676 E PT 1117676E PT 99947385 T PT99947385 T PT 99947385T PT 99947385 T PT99947385 T PT 99947385T PT 1117676 E PT1117676 E PT 1117676E
Authority
PT
Portugal
Prior art keywords
lipidicos
disturbios
metabolism
treatment
derivatives linked
Prior art date
Application number
PT99947385T
Other languages
English (en)
Portuguese (pt)
Inventor
Siegfried Stengelin
Alfons Enhsen
Heiner Glombik
Eugen Falk
Werner Kramer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT1117676E publication Critical patent/PT1117676E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PT99947385T 1998-10-02 1999-09-18 Derivados de propanolamina ligados a acidos biliares para o tratamento de disturbios no metabolismo dos lipidicos PT1117676E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19845403A DE19845403B4 (de) 1998-10-02 1998-10-02 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung

Publications (1)

Publication Number Publication Date
PT1117676E true PT1117676E (pt) 2004-11-30

Family

ID=7883185

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99947385T PT1117676E (pt) 1998-10-02 1999-09-18 Derivados de propanolamina ligados a acidos biliares para o tratamento de disturbios no metabolismo dos lipidicos

Country Status (22)

Country Link
US (1) US6180618B1 (https=)
EP (1) EP1117676B1 (https=)
JP (1) JP4598953B2 (https=)
KR (1) KR20010075511A (https=)
CN (1) CN1227259C (https=)
AR (1) AR035003A1 (https=)
AT (1) ATE273991T1 (https=)
AU (1) AU757366B2 (https=)
BR (1) BR9915019A (https=)
CA (1) CA2346085A1 (https=)
DE (2) DE19845403B4 (https=)
DK (1) DK1117676T3 (https=)
ES (1) ES2226440T3 (https=)
HK (1) HK1040717A1 (https=)
HU (1) HUP0103570A3 (https=)
ID (1) ID29353A (https=)
PL (1) PL347106A1 (https=)
PT (1) PT1117676E (https=)
RU (1) RU2234512C2 (https=)
TR (1) TR200100897T2 (https=)
WO (1) WO2000020437A1 (https=)
ZA (1) ZA200102586B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
GB0213669D0 (en) * 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892341A7 (fi) 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
GB2250634A (en) * 1990-12-04 1992-06-10 Marconi Gec Ltd Point contact diodes
NZ240846A (en) 1990-12-06 1994-04-27 Hoechst Ag Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
JP2616845B2 (ja) * 1991-02-21 1997-06-04 清水化学株式会社 システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
DK0557879T3 (da) * 1992-02-22 1997-06-16 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
TW289021B (https=) * 1993-05-08 1996-10-21 Hoechst Ag
EP0624593A3 (de) 1993-05-08 1995-06-07 Hoechst Ag Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
DK0869121T3 (da) * 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater

Also Published As

Publication number Publication date
HUP0103570A3 (en) 2003-01-28
DE19845403B4 (de) 2005-02-10
ID29353A (id) 2001-08-23
BR9915019A (pt) 2001-08-14
EP1117676B1 (de) 2004-08-18
DE59910300D1 (de) 2004-09-23
TR200100897T2 (tr) 2001-10-22
PL347106A1 (en) 2002-03-25
DK1117676T3 (da) 2004-12-20
CN1321166A (zh) 2001-11-07
EP1117676A1 (de) 2001-07-25
AR035003A1 (es) 2004-04-14
WO2000020437A1 (de) 2000-04-13
ZA200102586B (en) 2001-10-03
HUP0103570A2 (hu) 2002-02-28
JP4598953B2 (ja) 2010-12-15
RU2234512C2 (ru) 2004-08-20
ATE273991T1 (de) 2004-09-15
JP2002526550A (ja) 2002-08-20
HK1040717A1 (zh) 2002-06-21
AU6085599A (en) 2000-04-26
KR20010075511A (ko) 2001-08-09
AU757366B2 (en) 2003-02-20
US6180618B1 (en) 2001-01-30
ES2226440T3 (es) 2005-03-16
CN1227259C (zh) 2005-11-16
DE19845403A1 (de) 2000-04-13
CA2346085A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
ITMI20000662A0 (it) Derivati di ossime e loro impiego come acidi latenti
DE60043692D1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
FI972062A7 (fi) Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina
PT1147083E (pt) Derivados de arilpiperazinil-ciclohexilindole para o tratamento da depressao
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
FI950465A7 (fi) Läpäisevä laastari lääkityksen antamiseksi ihoon
PT861666E (pt) Composicao farmaceutica para utilizacao no tratamento da diabetes
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
BR9504072A (pt) Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit
FI971412A7 (fi) Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasie n estäjinä
PT1181027E (pt) Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria
IT1302365B1 (it) Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
EE200200628A (et) Dihüdroksüestrite ja nende derivaatide valmistamismeetod
FI19991896L (fi) Nikotiinihappokoostumuksia hyperlipemian hoitamiseksi ja vastaavia menetelmiä
FI951856A7 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
PT1117676E (pt) Derivados de propanolamina ligados a acidos biliares para o tratamento de disturbios no metabolismo dos lipidicos
FI972235L (fi) Menetelmä triaryylietyleenijohdannaisten käyttämiseksi osteoporoosin hoidossa ja ehkäisyssä
ID29792A (id) Formulasi lepas terkendali untuk mengobati corp
DE69925578D1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
PT1225902E (pt) Composicao farmaceutica contendo ciclesonide para aplicacao na mucosa
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
BR9505995A (pt) Composto método para tratamentos e composição farmacêutica
ITRM990707A0 (it) Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni
PT1051172E (pt) Metodo para tratamento da dpco